Spironolactone in the treatment of central serous chorioretinopathy – a case series

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 252, Issue 12, 2014, Pages 1985-1991

  Herold, T R ^a   Prause, K ^a   Wolf, A ^a   Mayer, W J ^a   Ulbig, M W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Central serous retinopathy; Choroid; Spironolactone; Subretinal fluid

Indexed keywords

MINERALOCORTICOID ANTAGONIST; SPIRONOLACTONE;

ADULT; CASE REPORT; CENTRAL SEROUS CHORIORETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERVENTION STUDY; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; SUBRETINAL FLUID; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADULT; CENTRAL SEROUS CHORIORETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROSPECTIVE STUDIES; SPIRONOLACTONE; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84933042786     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2780-6     Document Type: Article

References (13)

1. Zhao M, Celerier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, Behar-Cohen F (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672–2679. doi:10.1172/jci61427
2. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology 115(1):169–173. doi:10.1016/j.ophtha.2007.02.032
3. Gilbert CM, Owens SL, Smith PD, Fine SL (1984) Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol 68(11):815–820. doi:10.1136/bjo.68.11.815
4. Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29(10):1469–1473. doi:10.1097/IAE.0b013e3181be0a83
5. Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16(3):203–213
6. Steinle NC, Gupta N, Yuan A, Singh RP (2012) Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy. Br J Ophthalmol 96(1):10–13. doi:10.1136/bjophthalmol-2011-300183
7. Roisman L, Magalhaes FP, Lavinsky D, Moraes N, Hirai FE, Cardillo JA, Farah ME (2013) Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Ophthalmic Surg Lasers Imaging 44(5):465–470. doi:10.3928/23258160-20130909-08
8. Beger I, Koss MJ, Koch F (2012) Treatment of central serous chorioretinopathy: MicroPulse photocoagulation versus bevacizumab. Ophthalmologe 109(12):1224–1232. doi:10.1007/s00347-012-2688-7
9. Behnia M, Khabazkhoob M, Aliakbari S, Abadi AE, Hashemi H, Pourvahidi P (2013) Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy. Retina 33(2):324–328. doi:10.1097/IAE.0b013e3182670fa3
10. Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF (2014) Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Ophthalmology. doi:10.1016/j.ophtha.2013.11.040
11. Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 33(10):2096–2102. doi:10.1097/IAE.0b013e318297a07a
12. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure randomized aldactone evaluation study investigators. N Engl J Med 341(10):709–717. doi:10.1056/nejm199909023411001
13. Liew G, Quin G, Gillies M, Fraser-Bell S (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 41(2):201–214. doi:10.1111/j.1442-9071.2012.02848.x